- •Foreword
- •Foreword
- •Preface
- •Contents
- •Contributors
- •1.1 Introduction
- •1.2 Blepharoplasty
- •1.3 Forehead Lift
- •1.4 Midface
- •1.5 Conclusion
- •References
- •2.1 Introduction
- •2.2 Facial Proportions
- •2.3 Forehead
- •2.4 Eyebrows
- •2.5 Eyelid
- •2.5.1 Topography
- •2.5.2 Lamellae
- •2.5.3 Upper Eyelid Retractors
- •2.5.4 Tarsus
- •2.5.5 Lower Eyelid
- •2.6 Midface
- •2.6.1 Topography
- •2.6.2 Soft Tissue Lamellae
- •2.6.3 Nasojugal Groove
- •2.6.4 Malar Region
- •2.6.5 Nasolabial Region
- •2.7 Facial Vasculature, Innervation, and Lymphatic Drainage
- •2.8 Conclusion
- •References
- •3.1 Introduction
- •3.2 Specific Anatomic Subunits
- •3.3 Conclusion
- •References
- •4.1 Introduction
- •4.3 Examination of the Brow and Upper Eyelid Continuum
- •4.4 Examination of the Lower Eyelid and Cheek Continuum
- •4.5 Conclusion
- •References
- •5: Oculofacial Anesthesia
- •5.1 Introduction
- •5.2 Topical Anesthesia
- •5.2.1 Eye Drops
- •5.2.2 Topical Skin Creams
- •5.3 Local Injectable Anesthesia
- •5.4 Tumescent Anesthesia
- •5.5 Oral Sedation
- •5.6 Monitored Anesthesia Care
- •5.7 General Anesthesia
- •5.8 Issues for Consideration
- •5.9 Postoperative Care
- •5.10 Regional Nerve Blocks
- •5.11 Sensory Blocks
- •5.12 Conclusion
- •References
- •6: The Open Approach to Forehead Lifting
- •6.1 Introduction
- •6.2 Background
- •6.3 Anatomy
- •6.4 Preoperative Assessment
- •6.5 Technique
- •6.6 Postoperative Care
- •6.7 Complications
- •6.8 Conclusion
- •References
- •7.1 Introduction
- •7.2 Forehead and Temporal Anatomy
- •7.3 Aesthetics and Aging
- •7.4 Patient Selection
- •7.5 Instrumentation
- •7.5.1 Technique
- •7.5.2 Complications
- •7.6 Conclusion
- •References
- •8: Direct Brow Lift: An Aesthetic Approach
- •8.1 Introduction
- •8.2 Direct Eyebrow Lift
- •8.3 The Limited Lateral Supraciliary Eyebrow Lift Procedure
- •8.5 Scar Management
- •8.6 Conclusion
- •References
- •9: Upper Eyelid Blepharoplasty
- •9.1 Introduction
- •9.2 Anatomic Eyelid and Periorbital Considerations
- •9.3 Assessing Patients’ Concerns
- •9.4 Patient History
- •9.5 Patient Examination
- •9.6 Preparation for Surgery
- •9.7 Anesthesia
- •9.8 The Surgical Prep
- •9.9 The Surgery
- •9.10 Postoperative Management
- •9.11 Complications
- •9.12 Conclusion
- •References
- •10.1 Introduction
- •10.2 Anatomical Considerations and Preoperative Evaluation
- •10.3 Internal Brow Fat Sculpting and Elevation
- •10.3.1 Surgical Technique
- •10.4 Glabellar Myectomy
- •10.4.1 Surgical Technique
- •10.5 Lacrimal Gland Prolapse
- •10.5.1 Surgical Technique
- •10.6 Conclusion
- •References
- •11.1 Introduction
- •11.2 Complications
- •11.2.1 Hemorrhage
- •11.2.1.1 Eyelid Hematoma
- •Medical Management
- •Surgical Management
- •11.2.1.2 Retrobulbar/Intraorbital Hemorrhage
- •Medical Management
- •Surgical Management
- •11.2.2 Vision Loss
- •11.2.2.1 Orbital Compartment Syndrome
- •11.2.2.2 Globe Rupture/Perforation
- •Medical Management
- •Surgical Management
- •11.2.2.3 Corneal Abrasion
- •Medical Management
- •Surgical Management
- •11.2.3 Infection
- •11.2.3.1 Medical Management
- •11.2.3.2 Surgical Management
- •11.3 Surgical Complications
- •11.3.1 Lagophthalmos
- •11.3.1.1 Medical Management
- •11.3.1.2 Surgical Management
- •11.3.2 Dry Eye Syndrome
- •11.3.2.1 Medical Management
- •11.3.2.2 Surgical Management
- •11.3.3 Lacrimal Gland Injury
- •11.3.3.1 Medical Management
- •11.3.3.2 Surgical Management
- •11.3.4 Ptosis
- •11.3.4.1 Medical Management
- •11.3.4.2 Surgical Management
- •11.3.5 Diplopia
- •11.3.5.1 Medical Management
- •11.3.5.2 Surgical Management
- •11.3.6 Sulcus Deformity
- •11.3.6.1 Medical Management
- •11.3.6.2 Surgical Management
- •11.4 Incision Irregularities
- •11.4.1 Canthal Webbing
- •11.4.1.1 Medical Management
- •11.4.1.2 Surgical Management
- •11.4.2 Scarring
- •11.4.2.1 Medical Management
- •11.4.2.2 Surgical Management
- •11.4.3 Suture Milia
- •11.4.3.1 Medical Management
- •11.4.3.2 Surgical Management
- •11.5 Asymmetry
- •11.5.1 Lid Crease and Fold
- •11.5.1.1 Medical Management
- •11.5.1.2 Surgical Management
- •11.5.2 Skin
- •11.5.2.1 Medical Management
- •11.5.2.2 Surgical Correction
- •11.5.3.1 Medical Management
- •11.5.3.2 Surgical Management
- •11.5.4 Brow Position
- •11.5.4.1 Medical Management
- •11.5.4.2 Surgical Treatment
- •11.5.5 Undercorrection/Overcorrection
- •11.5.5.1 Medical Management
- •11.5.5.2 Surgical Management
- •11.6 Unrealized Patient Expectations
- •11.7 Conclusion
- •References
- •12.1 Introduction
- •12.2 Ptosis Repair: Which Approach?
- •12.3 Patient Evaluation
- •12.4 Anatomy
- •12.5 Procedure
- •12.6 Complications
- •12.7 Conclusion
- •References
- •13.1 Introduction
- •13.2 Preoperative Evaluation
- •13.2.1 Degree of Eyelid Ptosis
- •13.2.2 Levator Muscle Function
- •13.2.3 Phenylephrine Test
- •13.3 Anesthesia
- •13.4 Surgical Technique
- •13.4.1 Step 1: Eyelid Marking for Upper Blepharoplasty
- •13.4.2 Step 2: Instilling Local Anesthetic for Upper Blepharoplasty
- •13.4.3 Step 3: Performing the Frontal Block
- •13.4.4 Step 4: Placement of the Traction Suture
- •13.4.5 Step 5: Measuring Amount of Resection
- •13.4.6 Step 6: Separation of Conjunctiva and Müller’s Muscle
- •13.4.7 Step 7: Placement of the Ptosis Clamp
- •13.4.8 Step 8: Preventing Inappropriate Ptosis Clamp Placement
- •13.4.9 Step 9: Passage of Suture
- •13.4.10 Step 10: Excision of Conjunctiva and Müller’s Muscle
- •13.4.11 Step 11: Closure of Conjunctival Wound
- •13.4.12 Step 12: Burying the Suture Knot
- •13.4.13 Step 13: Completion of Upper Blepharoplasty
- •13.5 Postoperative Management
- •13.6 Complications
- •13.7 Conclusion
- •References
- •14.1 Introduction
- •14.2 Anatomic Considerations of the Asian Upper Eyelid
- •14.2.1 Musculature
- •14.2.2 Orbital Septum
- •14.2.3 Orbital Fat
- •14.2.4 Levator Palpebrae Superioris
- •14.3 Modern Management of the Upper Eyelid
- •14.5 Strategies for the Aging Asian Eyelid
- •14.5.1 Asians with a Natural Crease
- •14.5.2 Asians Without a Crease
- •14.5.3 Asians with Prior Surgery for Supratarsal Crease Formation
- •14.6 Eyelid Crease Formation
- •14.6.1 Preoperative Eye Evaluation and Crease Positioning
- •14.6.2 Surgical Marking
- •14.6.3 Anesthesia
- •14.6.4 Surgical Technique
- •14.6.4.1 Levator-to-Skin Fixation
- •14.6.5 Postoperative Care
- •14.7 Conclusion
- •References
- •15.1 Introduction
- •15.2 Patient Selection
- •15.3 Patient Examination
- •15.4 Eyelid Position and Laxity
- •15.5 Revision Patients
- •15.6 Festoons and Malar Edema
- •15.7 Patient Expectations and Psychology
- •15.8 Important Surgical Anatomy
- •15.9 Operative Technique
- •15.10 Fat Transposition
- •15.11 Lower Eyelid Tightening
- •15.12 Skin Resurfacing
- •15.13 Postoperative Care
- •15.14 Complications and Management
- •15.14.1 Milia
- •15.14.2 Dry Eye/Chemosis
- •15.14.3 Hematoma
- •15.14.4 Eyelid Malposition/Ectropion
- •15.15 Conclusion
- •References
- •16.1 Introduction
- •16.2 Lower Eyelid Anatomy
- •16.3 Eyelid Analysis/Preoperative Evaluation
- •16.5 Postoperative Care
- •16.6 Complications
- •16.7 Conclusion
- •References
- •17.1 Introduction
- •17.2 Canthal Anatomy
- •17.3 Patient Evaluation for Canthal Surgery
- •17.4 Surgical Techniques
- •17.4.1 Canthoplasty (Lateral Tarsal Strip)
- •17.4.2 Modified Canthoplasty
- •17.4.3 Canthopexy (Muscle suspension)
- •17.4.4 The Prominent Globe
- •17.5 Postoperative Care
- •17.6 Complications
- •17.7 Conclusion
- •References
- •18.1 Introduction
- •18.2 Anatomy of the Eyelid and Cheek
- •18.4 Presentation
- •18.5 Preoperative Evaluation
- •18.6 Surgical Procedures
- •18.7 Surgical Technique
- •18.7.1 Scar Lysis and Mobilization
- •18.7.2 Midface Elevation
- •18.7.3 Graft Placement
- •18.7.4 Lateral Canthal Resuspension
- •18.7.5 Eyelid Splinting and Casting
- •18.8 Conclusion
- •References
- •19: Laser Management of Festoons
- •19.1 Introduction
- •19.2 Laser Tissue Interactions
- •19.4 Treatment Protocols
- •19.5 Complications
- •19.6 Conclusion
- •References
- •20: Midface and Lower Eyelid Rejuvenation
- •20.1 Introduction
- •20.2 The Midface
- •20.3 Why I Prefer the Subperiosteal Face Lift
- •20.4 Patient Selection
- •20.5 Indications
- •20.6 Preoperative Preparation
- •20.7 Aesthetic Considerations
- •20.8 Technique
- •20.9 Lower Eyelid Blepharoplasty
- •20.10 Fat Grafting
- •20.12 Summary
- •References
- •21: Face Implants in Aesthetic Surgery
- •21.1 Introduction
- •21.2 Midface Treatment Options
- •21.3 Diagnosis and Implant Selection
- •21.4 Surgical Procedure
- •21.5 Postoperative Care and Healing
- •21.6 Implant Complications
- •21.7 Conclusion
- •21.8 Case Presentations
- •References
- •22: Periorbital Fat Grafting
- •22.1 Introduction
- •22.2 Analysis
- •22.2.1 Lower Eyelid
- •22.2.2 Upper Eyelid
- •22.3 Volume Source: Fat Versus Filler
- •22.4 Surgical Technique
- •22.4.1 General Considerations
- •22.4.2 Fat Harvest
- •22.4.3 Fat Processing
- •22.4.4 Fat Injection
- •22.5 Postoperative Considerations
- •22.6 Complications
- •22.7 Conclusion
- •References
- •23: Periorbital Laser Resurfacing
- •23.1 Introduction
- •23.2 History
- •23.3 Use of Resurfacing Lasers for Periorbital Resurfacing
- •23.4 Traditional Ablative Laser Resurfacing
- •23.7 Fractionated Laser Resurfacing
- •23.8 Technical Considerations: Nonablative Fractionated Laser
- •23.9 Posttreatment Care for Nonablative Fractionated Laser
- •23.10 Conclusion
- •24: Laser Incisional Eyelid Surgery
- •24.1 Introduction
- •24.2 History
- •24.3 Laser Incisions
- •24.4 Laser Safety
- •24.5 Upper Blepharoplasty
- •24.6 Lower Lid Transconjunctival Blepharoplasty
- •24.7 Ptosis Repair
- •24.8 Direct Brow Lift
- •24.10 Conclusion
- •References
- •25.1 Introduction
- •25.2 Review of Neuromodulators and Fillers: The Products
- •25.3 Treatments
- •25.3.1 Lateral Orbital Rhytids (Crow’s Feet)
- •25.3.2 Glabellar Complex
- •25.3.3 Frontalis Muscle
- •25.3.4 Nasojugal Groove/Tear Trough
- •25.4 Avoiding and Managing Complications
- •25.5 Conclusion
- •References
- •26: Management of the Prominent Eye
- •26.1 Introduction
- •26.2 Anatomic Associations of the Prominent Eye
- •26.3 Surgical Treatment of the Prominent Eye
- •26.3.1 Orbital Decompression Surgery
- •26.3.2 Cheek/Orbital Rim Implants
- •26.3.3 Repair of Eyelid Retraction
- •26.3.4 Upper Lid Retraction
- •26.3.5 Lower Lid Retraction
- •26.4 Cosmetic Treatment of the Tear Trough in the Prominent Eye
- •26.7 Conclusion
- •References
- •27.1 Introduction
- •27.2 Anti-metabolites
- •27.3 5-Fluorouracil
- •27.3.1 Mechanism of Action
- •27.3.2 Management
- •27.3.3 Safety
- •27.4 Corticosteroids
- •27.4.1 Mechanism of Action
- •27.4.2 Management
- •27.4.3 Safety
- •27.5 Fillers
- •27.5.1 Safety
- •27.6 Conclusions
- •References
- •28.1 History
- •28.3 Key Anatomic Features
- •28.4 Preoperative Assessment
- •28.5 Preoperative Care
- •28.6 Surgical Preparation and Technique
- •28.7 Postoperative Care
- •28.8 Potential Complications
- •28.9 Future Considerations
- •References
- •Index
110 |
C.N. Czyz et al. |
|
|
Fig. 11.1 Diffuse superficial hemorrhage following bilateral upper blepharoplasty in a patient who did not discontinue his daily 81 mg aspirin
Fig. 11.2 Computed tomography of the orbits (axial) shows proptosis and a compartmentalized intraorbital hemorrhage posteromedial to the left globe
and evaluating for proptosis, as a collection of blood in the orbit is more likely to threaten vision than a similar collection in the eyelid. If there is clinical uncertainty, a computed tomography (CT) scan of the orbits may be performed to confirm or help exclude the diagnosis of orbital hemorrhage (Fig. 11.2). In the absence of a retrobulbar hematoma, treatment should begin with conservative medical management.
Medical Management
The first step in the management of intraoperative hemorrhage is to identify and control any source of active bleeding. Small leaks may be initially controlled with direct pressure held over a period of time. For bleeding at the skin edge, this is sometimes preferable as cautery may cause thermal damage to the epithelium. If the surgical wound is closed and active bleeding is noted, this may necessitate reopening the wound, identifying the source of bleeding, and reapplying cautery. For actively “pumping” arteries, a forceps or hemostat is used
to grasp the vessel and stop the flow of blood. Cautery is then applied to the metallic instrument and transmitted to the tissue. In the rare circumstance that cautery is unsuccessful, thrombin, or gelfoam soaked in thrombin may be applied to the area to aid in hemostasis. If bleeding persists the vessel can be ligated with a suture when possible.
When a patient returns for a postoperative visit with an eyelid hematoma, and in the absence of active bleeding, treatment involves cold or warm compresses depending on the timing. For a diffuse (interstitial) collection of blood in the first 24–36 h after surgery, a cold compress will vasoconstrict blood vessels and decrease swelling, bleeding, and bruising. After this time, heat may speed up the breakdown and resorption of the blood. Small sequestered hematomas can be followed clinically (with compresses as above) until liquefaction has occurred. If the hematoma is localized and larger, needle aspiration should proceed. Patients who report bleeding after surgery should suspend anticoagulant therapy if medically possible. There are also many supplements and foods that affect the natural clotting process and should be discontinued until resolution of the hematoma [6] (Table 11.1).
Surgical Management
In severe or refractory cases, surgical exploration is necessary to identify and control the source of bleeding. Hematomas that continue to expand can be worrisome and lead to orbital compartment syndrome with possible permanent loss of vision.
11.2.1.2 Retrobulbar/Intraorbital Hemorrhage
Retrobulbar or intraorbital hemorrhage (Figs. 11.2 and 11.3) is one of the most feared complications of blepharoplasty. Retrobulbar hemorrhage causing orbital compartment syndrome is the most common cause of postoperative permanent vision loss. Presentation is commonly within the first 3 h after surgery, with the risk diminishing substantially after 24 h. Although less likely, hemorrhage can occur on a delayed basis. [7, 8]. In a questionnaire of members of the American Society of Ophthalmic Plastic and Reconstructive Surgery (ASOPRS), Hass et al. noted the incidence of retrobulbar hemorrhage after blepharoplasty to be 0.05% and retrobulbar hemorrhage associated with permanent vision loss 0.0045% [9]. The mechanism of permanent vision loss from retrobulbar hemorrhage is believed to be elevated intraocular and intraorbital pressure caused by the space-occupying hematoma. The rise in pressure can lead to compressive optic neuropathy or vascular ischemia of the optic nerve or retina [10–12].
Risk factors for retrobulbar hemorrhage are: thyroid associated orbitopathy, blood dyscrasias, hypertension, atherosclerosis, vascular disease, and anticoagulation [13]. Careful assessment of the patient’s risk factors for hemorrhaging
11 Management of Complications of Upper Eyelid Blepharoplasty |
111 |
|
|
Table 11.1 Medications and supplements that have effects on the natural clotting process
Advil |
|
Daypro |
Aggrenox |
|
Diflunisal |
Aleve |
|
Di-gesic |
Alka-Seltzer |
|
Dipridacot |
Anacin |
|
Dipyridamole |
Anaprox |
|
Disalcid |
Anadynos |
|
Dolobid |
Ansaid |
|
Dolpm |
APC |
|
Dong quai root |
Argesic |
|
Dristan |
Arthropan |
|
Duoprin |
Arthrotec |
|
Durgesic |
Arthritis pain formula |
|
Durasal |
ASA |
|
Easprin |
Axriptin |
|
Echinacea |
Asocdeen-30 |
|
Ecotrin |
Aspergum |
|
Emagrin |
Aspirin |
|
Emprazil |
Atromid |
|
Empirin with codeine |
Axotal |
|
Encaprin |
Azolid |
|
Ephedra (ma huang) |
Bayer products |
|
Equagesic |
B.C. tablets/powder |
|
Etodolac |
Bextra |
|
Etraqfon |
Bilberry |
|
Excedrin |
Bufferin products |
|
Feldene |
Buffets II |
|
Fenoprofen |
Buffinol |
|
Feverfew |
Buf-tabs |
|
Fiorinal |
Butalbital |
|
Fish oil |
Butazolidin |
|
Flaxseed |
Cama products |
|
Flurbiprofen |
Carisoprodol |
|
Four way cold tabs |
Cataflam |
|
Gaysal-S |
Chamomile |
|
Garlic |
Cheracol |
|
Gelprin |
Cilostazol (Pletal) |
|
Gemnisin |
Clinoril |
|
Ginger |
Clopidogrel |
|
Ginkgo biloba |
Congesprin chewable |
|
Ginseng |
Contac |
|
Goody’s |
Cope |
|
IBU |
Coricidin |
|
Ibuprofen |
Cosprin |
|
Indocin |
Coumadin |
|
Indomethacin |
CP-s |
|
Kava kava |
Damason P |
|
Ketoprofen |
Darvon |
|
Ketorolac |
Lanorinal |
|
Ponstel |
Lioresal |
|
Relafen |
Lodine |
|
Robaxisal |
Magan |
|
Rufin |
Magsal |
|
Ru-Tess |
Marnal |
|
S-A-C |
Meclofenamate |
|
Salatin |
Meclomen |
|
Saleto |
Mefenamic |
|
Saliflex |
Meloxicam |
|
Salicylamide |
Mendomen |
|
Salocol |
Melomen |
|
Salsalate |
Methocarbamol with Aspirin |
|
Selenium |
Micrainin |
|
Sine-aid |
Midol |
|
Sine-off sinus |
Mobic |
|
Sinutab |
Mobidin |
|
SK-65 |
Mobigesic |
|
Soma |
Momentum backache formula |
|
Stanback |
Monacet with Codeine |
|
Stendin |
Motrin |
|
St. John’s Wort |
Nabumetone |
|
St. Joseph’s products |
Nalfon |
|
Sulindac |
Naprelan |
|
Supac |
Naprosyn |
|
Synalgos-DC |
Naproxen |
|
Talwin compound |
Neocylate |
|
Ticlid |
Norgesic |
|
Ticlopidine |
Novnaproxen |
|
Tolectin |
Novodipiradol |
|
Tolmetin |
Nuprin |
|
Toradol |
Oraflex |
|
Triaminicin |
Orudis |
|
Trigesic |
Oruvail |
|
Trilisate |
Oxaprozin |
|
Valdecoxib |
P-A-C |
|
Valerian |
Pabalate-SF |
|
Vanquish |
Pabrin buffered tabs |
|
Vitamin E |
Pamprin |
|
Vivarin |
Panalgesic |
|
Voltaren |
Parnate |
|
Warfarin |
Pepto-BiPercodan |
|
Willow bark |
Persantine |
|
Yohimbe |
Persistin |
|
Zactrin |
Phenylbutaxone |
|
Zomac |
Plavix |
|
Zomax |
Pletal |
|
Zorprin |
Piroxicam |
|
|
should be performed prior to performing blepharoplasty. Any patient who complains of a constellation of symptoms including pain, asymmetric swelling, proptosis, dimming of vision, or loss of vision following blepharoplasty may have a retrobulbar hemorrhage and must be evaluated and treated promptly. A complete ophthalmic examination, including
visual acuity, pupil assessment, intraocular pressure, and dilated fundus examination is performed. However, if the clinical suspicion is high, none of these assessments should delay emergent surgical exploration. Clinical examination is usually sufficient for diagnosis, but as mentioned previously, orbital CT may be a useful adjunct.
